Trial intelligence / Profile preview

Effects of Neutral pH and Low GDP PDF on Inflammation and Endothelial Dysfunction

NCT01315314Phase 4Completed

Sponsor
Kyungpook National University Hospital
Start
Oct 2005
Primary completion
Apr 2008
Modality
Dialysis solution
Countries
1
01

Overview

Phase 4, randomised trial of balance in chronic kidney disease (CKD) (2 arms), sponsored by Kyungpook National University Hospital. Primary endpoint: Inflammation-endothelial-dysfunction index at 12 months. Started Oct 2005; status: completed.

02

Drugs

balance
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT01315314.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01315314.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call